PIK3CA and glioblastoma: Our ex vivo data are in line with our in vitro results, and clearly show that NMR may be used successfully to detect a decrease in several metabolites, in particular lactate and tCho following inhibition of the PI3K/mTOR pathway and radiation treatment of glioblastoma.